METHOD FOR THE PREPARATION OF A CHIRAL 4-ARYL-BETA-AMINO ACID DERIVATIVE

Description

FIELD OF THE INVENTION

[0001] The present invention relates to a method for preparing enantiomeric enriched β-amino acid derivatives. The β-amino acid derivatives are important intermediates in pharmacy, in particular, relates to a new method for preparing enantiomeric enriched β-amino acid derivatives for synthesizing sitagliptin for the treatment of diabetes.BACKGROUND OF THE INVENTION

[0002] As disclosed in J.Med.Chem.2005, 48(1):141, a general formula structure II is a dipeptidyl peptidase-IV (DPP-IV) inhibitor and a commercially available drug (Sitagliptin, Januvia) for the treatment of type II diabetes.

[0003] As disclosed in WO2004085378, WO2005097733, and WO2006065826, asymmetrically catalysis of enamines is in the presence of rhodium catalysts and Joshiphos ligands. However, special solvents are required, the amount of catalysts is relatively large, and the ee values of the obtained chiral product is relatively low, so as to make the method uneconomical.

[0004] As disclosed in WO2009064476, the intermediate chiral β-amino acid derivatives were prepared by asymmetric hydrogenation of enamines using BINAP-RuCl 2 as a catalyst. But, the ee values and yields of the obtained chiral products are relatively low.

[0005] As disclosed in US8278486 / CN102271504, the intermediate chiral β-amino acid derivatives were prepared by asymmetric hydrogenation of enamines using TangPhosRh(COD)BF 4 as a catalyst, and the ee value and yield of the obtained chiral products are relatively higher, but the cost of the catalyst ligand is higher, the commercial source is unstable. So there are risks in industrial applications.SUMMARY OF THE INVENTION

[0006] The present invention provides an effective enantioselective mode, and provides a method of preparing a chiral 4-aryl-β-amino acid derivative. The chiral 4-aryl-β-amino acid derivative is a β-amino acid derivative having a structure as shown in Formula I, wherein R-configuration or S-configuration is marked with * in the stereocenter; the preparation method comprises hydrogenating an enamine compound having a structure as shown in Formula III in an organic solvent in the presence of a catalyst containing a transition metal rhodium and BIBOPs; wherein Ar is a phenyl, substituted with 1-5 substituents or a mixture of 1-5 substituents independently selected from halogen, trifluoromethyl, alkoxy; PG is hydrogen, aldehyde group, acetyl, benzyl, Boc, Cbz, PMB, Fmoc, COOR 1< , CONR 2< ; Z is OR 1< , SR 1< and NR 3< R 4< ; wherein R 1< =H, C 1-6 alkyl; R 2< =H, C 1-6 alkyl or a three-membered to six-membered heterocycle containing nitrogen, oxygen and sulfur; R 3< and R 4< are each independently H, C 1-6 alkyl, C 4-10 cycloalkyl, aryl, or R 3< and R 4< bonded to a nitrogen atom to be formed a C 4-7 membered heterocycle having additional heteroatom optionally independently selected from O, S, N-C 1-5 alkyl.

[0007] In the technical solution of the preparation method of the present invention, the chiral ligands are BIBOPs (its preparation method can refer to US8552212, Org. Lett., 2010, 12(1):176), which has a structure as shown in Formula IV. The ligand BIBOPs has a structure as shown in Formula IV: wherein, R ' is hydrogen, alkyl, halogen, hydroxyl, alkoxy, aryl. Preferably, the configuration is Formula IVa, and R is methoxy.

[0008] In the technical solution of the preparation method of the present invention, the structural configuration as shown in Formula IV is a Formula (S,S,S',S')-IVa and a Formula (R,R,R',R')-IVb,

[0009] In the technical solution of the preparation method of the present invention, the transition metal comprises [M(NBD) 2 ]X, [M(COD) 2 ]X, wherein X is an uncoordinated anion selected from tetrafluoroborate, hexafluoroantimonate, trifluoromethanesulfonate; M is rhodium, iridium, ruthenium. Wherein COD is 1,5-cyclooctadiene, and NBD is norbornadiene. Preferably, the transition metal is [Rh(NBD) 2 ]BF 4 , [Rh(COD) 2 ]BF 4 .

[0010] In the technical solution of the preparation method of the present invention, preferably, the organic solvent is selected from one or more of methanol, ethanol, isopropanol, ethyl acetate, methyl acetate, butyl acetate, tetrahydrofuran, methyl tert-butyl ether, isopropyl ether, toluene, acetone, acetonitrile, dichloromethane and n-heptane. Preferably, the organic solvent is methanol or ethanol.

[0011] In the technical solution of the preparation method of the present invention, preferably, the amount of the chiral ligand and the transition metal is 0.001-1mol%.

[0012] In the technical solution of the preparation method of the present invention, preferably, the pressure of hydrogen is 0.1-10MPa, preferably, 0.1~2.5MPa.

[0013] In a technical solution of the preparation method of the present invention, preferably, the reaction temperature of the hydrogenation is from a room temperature to 100°C, preferably, from a room temperature to 80°C.

[0014] In the technical solution of the preparation method of the present invention, preferably, the reaction time of the hydrogenation is 2-36 hours, preferably, 6-24h.

[0015] The preparation method of the chiral β-amino acid derivative (Formula I) of the present invention has beneficial effects as follows: using a small amount of a selected asymmetric catalyst, and having a simple operation, mild reaction conditions, a high yield, a purity up to 99.9%, a high stereoselectivity, and better industrial application and economic values.DETAILED DESCRIPTION AND PREFERRED EMBODIMENTS THEREOF

[0016] Hereafter, the present invention will be described specifically with reference to the examples. The examples are given only for illustration of the technical solution of the present invention .Example 1: 5-[1-hydroxy-2-(2,4,5-trifluorophenyl)-ethylidene]-2,2-dimethyl-1,3-dioxane-4,6- diketone

[0017]

[0018] Add tetrahydrofuran (40.0g) and trifluorophenylacetic acid (10.0g) to a 250mL reaction kettle, control a temperature at 0~5°C, add in batches N,N-carbonyldiimidazole (CDI, 9.4g) to the reaction kettle, and react at a room temperature for 3h after finishing the addition, and continue to add a Meldrum's acid (8.4g) to stir at a room temperature for 16h. And then evaporate solvents under reduced pressure, add water (20.0 g), adjust pH to pH=2 with 1N hydrochloric acid, extract with dichloromethane, wash and dry to obtain white solids [5-[1-hydroxy-2-(2,4,5-trifluorophenyl)-ethylidene]-2,2-dimethyl- 1,3-dioxane-4,6-diketone] 14.6g, the yield is 88%. HRMS[M+H] +< : 317.0628; 1< H-NMR (400MHz, CDCl 3 ) : 15.50 (s, 1H) , 7.13-7.19 (m, 1H) , 6.93-6.99 (m, 1H) , 4.54 (s, 2H) , 1.77 (s, 6H) .Example 2: (Z)-3-amino-4-(2,4,5-trifluorophenyl)-2-methyl crotonate

[0019]

[0020] Add methanol (48.0g), the product 5-[1-hydroxy-2-(2,4,5-trifluorophenyl)- ethylidene]-2,2-dimethyl-1,3-dioxane-4,6-diketone (14.0g) of Example 1 to a 250mL reaction kettle, react at 60°C for 4h, and then add ammonium acetate (5.0g), react at 60°C for 10h, afterwards concentrate under reduced pressure, add in turn dichloromethane and water, and then extract, wash, dry, and recover solvent to dryness under reduced pressure, to obtain a light yellow solid of [(Z)-3-amino-4-(2,4,5-trifluorophenyl)-2-methyl crotonate] 10.0g, the yield is 92%. HRMS[M+H] +< : 246.0735; 1< H-NMR (400MHz, CDCl 3 ) : 7.05-7.12 (m, 1H) , 6.92-6.98 (m, 1H) , 4.57 (s, 1H) , 3.65 (s, 3H) , 3.41 (s, 2H) .Example 3: (Z)-3-acetamido-4-(2,4,5-trifluorophenyl)-2-methyl crotonate

[0021]

[0022] Add tetrahydrofuran(40.0g), the product (Z)-3-amino-4-(2,4,5-trifluorophenyl)-2- methyl crotonate (10.0g) of Example 2, acetic anhydride (8.0g), pyridine (9.0g) to a 100mL reaction flask to react under reflux for 20h, adjust pH to pH=3 with hydrochloric acid. And then evaporate solvents to dryness under reduced pressure, and purify by silica gel to obtain 9.3g white solid [(Z)-3-acetamido-4-(2,4,5-trifluorophenyl)-2-methyl crotonate] (79% of the yield, 99.8% ofHPLC purity). HRMS[M+H] +< : 288.0838; 1< H-NMR (400MHz, CDCl 3 ) : 11.14 (s, 1H) , 7.03-7.09 (m, 1H) , 6.89-6.96 (m, 1H) , 4.82 (s, 1H) , 4.15 (s, 2H) , 3.71 (s, 3H) , 2.15 (s, 3H) .Example 4: (3R)-N-acetyl-3-amino-4-(2,4,5-trifluorophenyl)methyl butyrate

[0023]

[0024] Add methanol (16.0g), the product (Z)-3-acetamido-4-(2,4,5-trifluorophenyl)-2- methyl crotonate (4.0g) of Example 3, MeO-BIBOP / [Rh(NBD) 2 ]BF 4 (2.0mg) to a hydrogenated kettle, replaced with nitrogen and hydrogen successively, the hydrogen pressure is up to 1.0Mpa, react at a room temperature for 36h, and then evaporate solvents to dryness under reduced pressure, to obtain (3R)-N-acetyl-3-amino-4- (2,4,5-trifluorophenyl)methyl butyrate, the quantitative yield is 98.8%ee, and the purity is 99.4%. HRMS[M+H] +< : 290.0998; 1< H-NMR (400MHz, CDCl 3 ) : 7.02-7.09 (m, 1H) , 6.87-6.93 (m, 1H) , 6.31-6.33 (m, 1H) , 4.44-4.45 (m, 1H) , 3.71 (s, 3H) , 2.87-2.89 (m, 2H) , 2.49-2.61 (m, 2H) 1.93 (s, 3H) .Example 5: (3R)-N-acetyl-3-amino-4-(2,4,5-trifluorophenyl)methyl butyrate

[0025]

[0026] Add ethanol (10.0g), the product (Z)-3-acetamido-4-(2,4,5-trifluorophenyl)-2- methyl crotonate (2.0g) of Example 3, MeO-BIBOP / [Rh(NBD) 2 ]BF 4 (1.0mg) to a hydrogenated kettle, replace with nitrogen and hydrogen successively, the hydrogen pressure is up to 1.0Mpa, and afterwards react at 60°C for 18h, and then evaporate solvents to dryness under reduced pressure, to obtain (3R)-N-acetyl-3-amino-4- (2,4,5-trifluorophenyl)methyl butyrate, the quantitative yield is 98.5%ee, the purity is 99.4%.Example 6: (3R)-N-acetyl-3-amino-4-(2,4,5-trifluorophenyl)methyl butyrate

[0027]

[0028] Add tetrahydrofuran (10.0g), the product (Z)-3-acetamido-4-(2,4,5-trifluorophenyl) -2-methyl crotonate (2.0g) of Example 3, MeO-BIBOP / [Rh(NBD) 2 ]BF 4 (1.0mg) to a hydrogenated kettle, replace with nitrogen and hydrogen successively, the hydrogen pressure is up to 1.5Mpa, and afterwards react at 50°C for 10h, and then evaporate solvents to dryness under reduced pressure, to obtain (3R)-N-acetyl-3-amino- 4-(2,4,5-trifluorophenyl) methyl butyrate, the quantitative yield is 98.8%ee, the purity is 99.7%.Example 7: (3R)-N-acetyl-3-amino-4-(2,4,5-trifluorophenyl)methyl butyrate

[0029]

[0030] Add methanol (10.0g), the product (Z)-3-acetamido-4-(2,4,5-trifluorophenyl)- 2-methyl crotonate (2.0g) of Example 3, MeO-BIBOP / [Rh(NBD) 2 ]BF 4 (1.0mg) to a hydrogenated kettle, replace with nitrogen and hydrogen successively, the hydrogen pressure is up to 2.5Mpa, and afterwards react at 60°C for 6h, and then evaporate solvents to dryness under reduced pressure, to obtain (3R)-N-acetyl-3-amino-4- (2,4,5-trifluorophenyl)methyl butyrate, the quantitative yield is 98.2%ee, the purity is 99.8%.Example 8: (3R)-N-acetyl-3-amino-4-(2,4,5-trifluorophenyl)methyl butyrate

[0031]

[0032] Add methanol (10.0g), the product (Z)-3-acetamido-4-(2,4,5-trifluorophenyl)-2- methyl crotonate (2.0g) of Example 3, MeO-BIBOP / [Rh(COD) 2 ]BF 4 (1.5mg) to a hydrogenated kettle, replace with nitrogen and hydrogen successively, the hydrogen pressure is up to 1.0Mpa, and afterwards react at 40°C for 24h, and then evaporate solvents to dryness under reduced pressure, to obtain (3R)-N-acetyl-3-amino- 4-(2,4,5-trifluorophenyl)methyl butyrate, the quantitative yield is 98.5%ee, and the purity is up to 99.5%.Example 9: (3R)-N-acetyl-3-amino-4-(2,4,5-trifluorophenyl)methyl butyrate

[0033]

[0034] Add methanol (16.0g), (Z)-3-acetamido-4-(2,4,5-trifluorophenyl)-2-ethyl crotonate (4.0g), MeO-BIBOP / [Rh(NBD) 2 ]BF 4 (2.0mg) to a hydrogenated kettle, replace with nitrogen and hydrogen successively, the hydrogen pressure is up to 1.0Mpa, and afterwards react at 50°C for 14h, and then evaporate solvents to dryness under reduced pressure, to obtain (3R)-N-acetyl-3-amino-4-(2,4,5-trifluorophenyl)ethyl butyrate, the quantitative yield is 98.7%ee, the purity is 99.8%. HRMS[M+H] +< : 304.1150; 1< H-NMR (400MHz, CDCl 3 ) : 7.04-7.10 (m, 1H) , 6.88-6.93 (m, 1H) , 6.30-6.33 (m, 1H) , 4.42-4.45 (m, 1H) , 4.10 (q, J=7.2Hz, 2H) 3.72 (s, 3H) , 2.87-2.90 (m, 2H) , 2.49-2.61 (m, 2H) 1.26 (t, J=6.8Hz, 3H) .Example 10: (3R)-N-acetyl-3-amino-4-(2,4,5-trifluorophenyl)methyl butyrate

[0035]

[0036] Add methanol (10.0g), the product (Z)-3-acetamido-4-(2,4,5-trifluorophenyl)-2- methyl crotonate (2.0g) of Example 3, MeO-BIBOP / [Rh(NBD)]SbF 6 (1.5mg) to a hydrogenated kettle, replace with nitrogen and hydrogen successively, the hydrogen pressure is up to 1.0Mpa, and afterwards react at 50°C for 24h, and then evaporate solvents to dryness under reduced pressure, to obtain (3R)-N-acetyl-3-amino-4- (2,4,5-trifluorophenyl)methyl butyrate, the quantitative yield is 98.0%ee, and the purity is up to 99.0%.Example 11: (3R)-N-tert-butoxycarbonyl-3-amino-4-(2,4,5-trifluorophenyl)methyl butyrate

[0037]

[0038] Add (3R)-N-acetyl-3-amino-4-(2,4,5-trifluorophenyl) methyl crotonate (3.0g) and hydrochloric acid (9.0g) to a 50mL reaction flask, react under reflux overnight, and then concentrate under reduced pressure, and afterwards add 2mol / L NaOH solution to adjust pH > 13.5, dropwise add Boc-anhydride (2.7g), and react at room temperature for 5h. Add ethyl acetate (9.0 g), adjust pH to pH=2.5~3.5 with 2N hydrochloric acid, layer, extract, wash, and reduce to dryness, to obtain a white solid of (3R)-N-tert- butoxycarbonyl -3-amino-4- (2,4,5-trifluorophenyl)methyl butyrate 3.1 g, the yield is 90%, the purity is 99.7%. HRMS[M+H] +< : 334.1276; 1< H-NMR (400MHz, DMSO-d 6 ) : 12.19 (s, 1H) 7.41-7.48 (m, 1H) , 7.24-7.31 (m, 1H) , 6.77-6.79 (d, 1H, J=8.8Hz) , 4.00-4.02 (m, 1H) , 2.57 (dd, 1H, J=3.2, 13.2Hz) , 2.83 (dd, 1H, J=4.4, 15.2Hz) , 2.40 (d, 2H, J=6.4Hz) 1.27 (s, 9H) .Example 12: N-Boc sitagliptin

[0039]

[0040] Add dichloromethane (30.0g), (3R)-N-tert-butoxycarbonyl-3-amino-4-(2,4,5-trifluorophenyl) methyl butyrate (3.0g), 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4] triazolo [4,3-a]pyrazine hydrochloride (2.4g) to a 250mL reaction flask, and then add HOBT ( 1.4g), EDC•HCl (1.9g) to the reaction flask, control a temperature to 0.0~10.0°C, and afterwards slowly add DIPEA (3.5g) and react at a room temperature for 12h. Add water (70.0g) after finishing the reaction, evaporate solvents under reduced pressure, add anhydrous ethanol ( 24.0g) to raise the temperature to dissolve, and then filter, crystallize by cooling, and then dry to obtain 3.75 g of a white solid (a yield is 82%). HRMS[M+H] +< : 508.1666; 1< H-NMR (400MHz, DMSO-d 6 ) : 7.40-7.47 (m, 1H) , 7.29-7.36 (m, 1H) , 6.74-6.77 (m, 1H) , 4.88-5.04 (m, 2H) , 4.22-4.32 (m, 1H) , 3.96-4.10 (m, 2H) , 2.61-2.89 (m, 4H) 1.24 (s, 9H) .Example 13: Sitagliptin

[0041]

[0042] Add in turn methanol (10.0g) and N-Boc sitagliptin (2.0g) to a 100mL reaction flask, slowly add hydrochloric acid (4.5g) and react at room temperature for 14h, concentrate under reduced pressure after finishing the reaction, and then add water (2.5g) under stirring, and adjust pH with the sodium hydrogen solution to pH=8.0~9.0, add ethyl acetate for extraction, and then concentrate under reduced pressure, and recrystallize with isopropanol (10.0 g), to obtain 1.3 g of white solid (yield is 80%, ≥99.9% ee). HRMS[M+H] +< : 408.1260; 1< H-NMR (400MHz, D 2 O) : 7.17-7.24 (m, 1H) , 7.01-7.11 (m, 1H) , 4.82-5.00 (m, 2H) , 4.14-4.27 (m, 2H) , 3.93-4.01 (m, 1H) , 2.91-3.09 (m, 2H) , 2.79-2.97 (m, 2H) .Example 14: N-Boc sitagliptin

[0043]

[0044] Add methanol (10.0g), (Z)-tert-butoxycarbonyl-4-oxo-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]triazolo[4,3-a]pyrazinyl-7(8H)-yl]-1-(2,4,5-trifluorophenyl)-butyl-2-en-2-ylcarbamate (2.0g), MeO-BIBOP / [Rh(NBD) 2 ]BF 4 (2.0mg) to a hydrogenated kettle, replace with nitrogen and hydrogen successively, the hydrogen pressure is up to 1.5Mpa, and afterwards react at 50°C for 16h, and then evaporate solvents to dryness under reduced pressure, to obtain a quantitative yield is 90.0% ee.Example 15: (3R)-N-acetyl-3-amino-4-(2,4,5-trifluorophenyl) methyl butyrate

[0045]

[0046] Add methanol (10.0g), (Z)-3-tert-butoxycarbonylamino-4-(2,4,5-trifluorophenyl) -2-methyl crotonate (2.0g), MeO-BIBOP / [Rh(NBD) 2 ]BF 4 (1.0mg) to a hydrogenated kettle, replace with nitrogen and hydrogen successively, the hydrogen pressure is up to 1.0Mpa, and afterwards react at 50°C for 14h, and then filter and evaporate to dryness under reduced pressure, to obtain a quantitative yield is 99.3% ee, the purity is 99.9%. HRMS[M+H] +< : 348.1421; 1< H-NMR (400MHz, CDCl 3 ) : 7.04-7.12 (m, 1H) , 6.84-6.93 (m, 1H) , 5.09-5.12 (m, 1H) , 4.10-4.22 (m, 1H) , 3.70 (s, 3H) , 2.85-2.90 (m, 1H) , 2.50-2.61 (m, 1H) , 1.40 (s, 9H) .

[0047] The present invention is not limited by the above-mentioned examples. The above-mentioned examples and descriptions are only for illustrating the principle.

Claims

1. A method for preparing a chiral 4-aryl-β-amino acid derivative, the chiral 4-aryl-β-amino acid derivative is a β-amino acid derivative having a structure as shown in Formula I, wherein R-configuration or S-configuration is marked with * in the stereocenter; the preparation method comprises hydrogenating an enamine compound having a structure as shown in Formula III in an organic solvent in the presence of a catalyst containing a transition metal and BIBOPs; wherein Ar is a phenyl, substituted with 1-5 substituents or a mixture of 1-5 substituents independently selected from halogen, trifluoromethyl, alkoxy; PG is hydrogen, aldehyde group, acetyl, benzyl, Boc, Cbz, PMB, Fmoc, COOR1, CONR2; Z is OR1, SR1 and NR3R4; wherein R1=H, C1-6 alkyl; R2=H, C1-6 alkyl or three-membered to six-membered heterocycle containing nitrogen, oxygen and sulfur; R3 and R4 are each independently H, C1-6 alkyl, C4-10 cycloalkyl, aryl, or R3 and R4 bonded to a nitrogen atom to be formed a C4-7 membered heterocycle having additional heteroatom optionally independently selected from O, S, N-C1-5 alkyl: wherein the transition metal comprises [M(NBD)2]X, [M(COD)2]X, wherein X is selected from an uncoordinated anion of tetrafluoroborate, hexafluoroantimonate, trifluoromethanesulfonate; M is rhodium, iridium, ruthenium; and wherein a ligand BIBOPs has a structure as shown in Formula IV: wherein R' is hydrogen, alkyl, halogen, hydroxyl, alkoxy, aryl.

2. The method according to claim 3, wherein a structural configuration as shown in Formula IV is formula (S,S,S',S')-IVa and formula (R,R,R',R ')-IVb, 3. The method according to claim 1, wherein the organic solvent is selected from one or more of methanol, ethanol, isopropanol, ethyl acetate, methyl acetate, butyl acetate, tetrahydrofuran, methyl tert-butyl ether, isopropyl ether, toluene, acetone, acetonitrile, dichloromethane and n-heptane.

4. The method according to claim 1, wherein Ar in Formula III is 2,4,5-trifluorophenyl, PG is acetyl, Z is OCH3.

5. The method according to claim 1, wherein Ar in Formula III is 2,4,5-trifluorophenyl, PG is Boc, Z is 6. The method according to claim 1, wherein the pressure of hydrogen is 0.1-10MPa.

7. The method according to claim 1, wherein the reaction temperature of the hydrogenation is from a room temperature to 100°C.

8. The method according to claim 1, wherein the reaction time of the hydrogenation is 2-36 hours.